Ticker Details
Climb Bio, Inc. Common Stock
IPO Date:	August 10, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$383.88M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.55%
Avg Daily Range (30 D):	$0.26 | 5.43%
Avg Daily Range (90 D):	$0.19 | 5.46%

Institutional Daily Volume
Avg Daily Volume:	.26M
Avg Daily Volume (30 D):	.58M
Avg Daily Volume (90 D):	1.06M

Trade Size
Avg Trade Size (Sh.):	147
Avg Trade Size (Sh.) (30 D):	103
Avg Trade Size (Sh.) (90 D):	154

Institutional Trades
Total Institutional Trades:	63
Avg Institutional Trade:	$1.93M
Avg Institutional Trade (30 D):	$1.15M
Avg Institutional Trade (90 D):	$1.72M
Avg Institutional Trade Volume:	.44M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.54M
Avg Closing Trade (30 D):	$1.15M
Avg Closing Trade (90 D):	$1.44M
Avg Closing Volume:	566.25K

News

Feb 5, 2026 @ 12:00 PM Climb Bio to Present at Upcoming Investor Conferen... Source: Not Specified

Nov 25, 2025 @ 12:00 PM Climb Bio Reports Inducement Grant Under Nasdaq Li... Source: Carlo Tanzi, Ph.D.

Oct 17, 2025 @ 11:00 AM Climb Bio to Present Data at American Society of N... Source: Climb Bio, Inc.

Aug 25, 2025 @ 6:41 PM UPDATE – Climb Bio to Present at Upcoming S... Source: Carlo Tanzi, Ph.D.

May 19, 2025 @ 8:34 PM Climb Bio Reports Inducement Grant Under Nasdaq Li... Source: Na

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.59	$-.19	$-.13
Diluted EPS	$-.59	$-.19	$-.13
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-50.75M	$-12.89M	$-8.67M
Operating Income / Loss	$-59.5M	$-14.89M	$-10.68M
Cost of Revenue
Net Cash Flow	$-58.89M	$M	$M
PE Ratio